GOLDENWELL BIOTECH, INC. Annual Cost of Revenue in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Goldenwell Biotech, Inc. quarterly/annual Cost of Revenue history and growth rate from 2019 to 2023.
  • Goldenwell Biotech, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Goldenwell Biotech, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $335.000, a 67.9% decline year-over-year.
  • Goldenwell Biotech, Inc. annual Cost of Revenue for 2023 was $1.23K, a 94.6% decline from 2022.
  • Goldenwell Biotech, Inc. annual Cost of Revenue for 2022 was $22.6K, a 198% increase from 2021.
  • Goldenwell Biotech, Inc. annual Cost of Revenue for 2021 was $7.58K.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.